Triple-Leveraged Biotech ETFs Could be Coming Soon

Direxion has already found success with leveraged healthcare ETFs. The Direxion Daily Healthcare Bull 3x Shares (NYSEArca: CURE), the triple-leveraged answer to the Health Care Select Sector SPDR (NYSEArca: XLV), the largest health care ETF, has surged 88% over the past year on its way to amassing $300 million in assets under management. [A Cure for the Ordinary Healthcare ETF]

Direxion’s SEC filing also revealed plans for the Direxion Daily S&P Oil Services Bull 3X Shares and the Direxion Daily S&P Oil Services Bear 3X Shares. Those ETFs would use the S&P Oil & Gas Exploration & Production Select Industry Index as their underlying benchmark. That is the same index tracked by the SPDR S&P Oil & Gas Exploration & Production ETF (NYSEArca: XOP).

Those leveraged ETFs would also charge 0.95% per year if they come to market.

SPDR S&P Biotech ETF

ETF Trends editorial team contributed to this post.